A sequential treatment regimen with melatonin and all-trans retinoic acid induces apoptosis in MCF-7 tumour cells.

[1]  S. Hill,et al.  Melatonin modulation of estrogen‐regulated proteins, growth factors, and proto‐oncogenes in human breast cancer , 1995, Journal of pineal research.

[2]  M. Lippman,et al.  Binding of retinoids to human breast cancer cell lines and their effects on cell growth. , 1980, The Journal of clinical investigation.

[3]  Forrest Ap.  ENDOCRINE TREATMENT OF BREAST CANCER. , 1965 .

[4]  W. Miller,et al.  Endocrine treatment for breast cancers: Biological rationale and current progress , 1990, The Journal of Steroid Biochemistry and Molecular Biology.

[5]  S. Bacus,et al.  Differentiation of cultured human breast cancer cells (AU‐565 and MCF‐7) associated with loss of cell surface HER‐2/neu antigen , 1990, Molecular carcinogenesis.

[6]  S. Hill,et al.  Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells. , 1994, Molecular endocrinology.

[7]  S. Cos,et al.  Differences between pulsatile or continuous exposure to melatonin on MCF-7 human breast cancer cell proliferation. , 1994, Cancer letters.

[8]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[9]  John Calvin Reed,et al.  Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. , 1995, Cancer research.

[10]  S. Reppert,et al.  Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[11]  O. Werz,et al.  The Nuclear Receptor for Melatonin Represses 5-Lipoxygenase Gene Expression in Human B Lymphocytes (*) , 1995, The Journal of Biological Chemistry.

[12]  J. Fontana,et al.  Retinoid modulation of estradiol-stimulated growth and of protein synthesis and secretion in human breast carcinoma cells. , 1990, Cancer research.

[13]  V. Giguère,et al.  Identification of a receptor for the morphogen retinoic acid , 1987, Nature.

[14]  J. Gusella,et al.  Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1b melatonin receptor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Rubin,et al.  9-Cis retinoic acid inhibits growth of breast cancer cells and down-regulates estrogen receptor RNA and protein. , 1994, Cancer research.

[16]  S. Hill,et al.  Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. , 1988, Cancer research.

[17]  J. Saurat,et al.  Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. , 1997, The Journal of Biological Chemistry.

[18]  J. Graham,et al.  Progesterone receptor regulation by retinoic acid in the human breast cancer cell line T-47D. , 1990, The Journal of biological chemistry.

[19]  R. Lotan.  Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibition. , 1979, Cancer research.

[20]  B. Burg,et al.  Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function , 1993, Molecular and Cellular Endocrinology.

[21]  D. Leroith,et al.  Retinoid modulation of insulin-like growth factor-binding proteins and inhibition of breast carcinoma proliferation. , 1991, Endocrinology.

[22]  R. Coffey,et al.  Growth stimulation of human breast cancer cells with anti-transforming growth factor beta antibodies: evidence for negative autocrine regulation by transforming growth factor beta. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[23]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[24]  M. Pfahl,et al.  A new retinoic acid receptor identified from a hepatocellular carcinoma , 1988, Nature.

[25]  K. Franssila,et al.  Reduced expression of proapoptotic gene BAX is associated with poor response rates to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. , 1995, Cancer research.